H.C. Wainwright initiated coverage of Envoy Medical (COCH) with a Buy rating and $2.50 price target Envoy is a commercial-stage medical device company focused on the development of novel devices for patients with hearing loss, the analyst tells investors in a research note. The firm says the company’s Acclaim Cochlear Implant may be the world’s first fully implanted cochlear implant.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COCH: